CACNB4 attenuates cardiac dysfunction by regulating calcium and ATP levels via interaction with RyR2

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• The precise role of CACNB4 in cardiac contraction remains unclear.
• Understanding CACNB4's function is crucial for developing heart failure therapies.

Purpose of the Study:

• To investigate the role of CACNB4 in heart failure.
• To elucidate the molecular mechanisms underlying CACNB4's function in cardiac muscle.

Main Methods:

• Analysis of gene expression profiles from heart failure patients (GSE235757 dataset).
• KEGG pathway enrichment analysis.
• Western blot analysis in hypoxic myocardial cells and heart failure mouse models.
• Functional studies involving CACNB4 overexpression.

Main Results:

• CACNB4 expression was significantly downregulated in heart failure patients' PBMCs and in mouse models.
• Downregulation of CACNB4 was linked to the "Cardiac muscle contraction" pathway.
• Overexpression of CACNB4 improved cardiac function, reduced infarct size, and alleviated myocardial damage.
• CACNB4 enhances intracellular ATP and Ca2+ levels, partly through interaction with RyR2.

Conclusions:

• CACNB4 plays a critical role in maintaining cardiac function.
• CACNB4 interacts with RyR2 to regulate intracellular Ca2+ and ATP levels.
• Targeting CACNB4 may offer a therapeutic strategy for heart failure.